Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau

Neuroscience

Volumn 193, Issue , 2011, Pages 330-337

  Zilka, N ^a,b   Zilkova, M ^a,b   Kazmerova, Z ^a   Sarissky, M ^c   Cigankova, V ^d   Novak, M ^a,b  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b Axon Neuroscience Forschungs und Entwicklungs GmbH   (Austria)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

^d UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

Author keywords

Alzheimer's disease; Mesenchymal stem cells; Truncated tau protein

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; IMMUNOMODULATION; MALE; MESENCHYMAL STEM CELL; NEURITE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; RAT; TRANSGENE;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; APOPTOSIS; BONE MARROW CELLS; CASPASE 3; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL SURVIVAL; COCULTURE TECHNIQUES; HUMANS; MALE; MESENCHYMAL STEM CELLS; NERVE GROWTH FACTORS; NEUROBLASTOMA; PHOSPHORYLATION; RATS; RATS, WISTAR; TAU PROTEINS; TIME FACTORS; TRANSFECTION; TRETINOIN;

EID: 80052496433     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.06.088     Document Type: Article

References (41)

1. Abemayor E., Sidell N. Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ Health Perspect 1989, 80:3-15.
2. Bianco P., Robey P.G., Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2(4):313-319.
3. Blurton-Jones M., Kitazawa M., Martinez-Coria H., Castello N.A., Müller F.J., Loring J., Yamasaki T.R., Poon W.W., Green K.N., LaFerla F.M. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 2009, 106(32):13594-13599.
4. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82(4):239-259.
5. Braak H., Rüb U., Schultz C., Del Tredici K. Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. J Alzheimers Dis 2006, 9(Suppl 3):35-44.
6. Brunden K.R., Ballatore C., Crowe A., Smith A.B., Lee V.M., Trojanowski J.Q. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol 2010, 223(2):304-310.
7. Brunden K.R., Trojanowski J.Q., Lee V.M. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 2009, 8(10):783-793.
8. Caplan A.I. Mesenchymal stem cells. J Orthop Res 1991, 9(5):641-650.
9. Clagett-Dame M., McNeill E.M., Muley P.D. Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J Neurobiol 2006, 66:739-756.
10. Colter D.C., Sekiya I., Prockop D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001, 98(14):7841-7845.
11. Crigler L., Robey R.C., Asawachaicharn A., Gaupp D., Phinney D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006, 198(1):54-64.
12. Delacourte A., David J.P., Sergeant N., Buée L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999, 52(6):1158-1165.
13. Dezawa M. Insights into autotransplantation: the unexpected discovery of specific induction systems in bone marrow stromal cells. Cell Mol Life Sci 2006, 63(23):2764-2772.
14. Dickey C.A., Petrucelli L. Current strategies for the treatment of Alzheimer's disease and other tauopathies. Expert Opin Ther Targets 2006, 10:665-676.
15. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Ceña V., Gallego C., Comella J.X. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 2000, 75(3):991-1003.
16. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986, 261:6084-6089.
17. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986, 83:4913-4917.
18. Hampton D.W., Webber D.J., Bilican B., Goedert M., Spillantini M.G., Chandran S. Cell-mediated neuroprotection in a mouse model of human tauopathy. J Neurosci 2010, 30(30):9973-9983.
19. Iqbal K., Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 2008, 12(1):38-55.
20. Javazon E.H., Colter D.C., Schwarz E.J., Prockop D.J. Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells 2001, 19(3):219-225.
21. Joyce N., Annett G., Wirthlin L., Olson S., Bauer G., Nolta J.A. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010, 5(6):933-946.
22. Kassis I., Vaknin-Dembinsky A., Karussis D. Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther 2010, 164(11):1015-1022.
23. Lee HJ, Lee JK, Lee H, Carterd JE, Change JW, Ohe W, Yange YS, Suhf JG, Lee BH, Jin HJ, Bae JS (in press) Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol Ageing.
24. Lee J.K., Jin H.K., Endo S., Schuchman E.H., Carter J.E., Bae J.S. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 2010, 28:329-343.
25. Lee V.M., Balin B.J., Otvos L., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 1991, 251(4994):675-678.
26. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59:514-523.
27. Lindvall O., Björklund A. Cell therapy in Parkinson's disease. NeuroRx 2004, 1(4):382-393.
28. Mahmood A., Lu D., Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 2004, 55:1185-1193.
29. Nikolic W.V., Hou H., Town T., Zhu Y., Giunta B., Sanberg C., Zeng J., Luo D., Ehrhart J., Mori T., Sanberg P.R., Tan J. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev 2008, 17:423-439.
30. Novak M., Jakes R., Edwards P.C., Milstein C., Wischik C.M. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci U S A 1991, 88:5837-5841.
31. Novak M., Kabat J., Wischik C.M. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 1993, 12:365-370.
32. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276(5309):71-74.
33. Schneider A., Mandelkow E. Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics 2008, 5(3):443-457.
34. Schwarz S.C., Schwarz J. Translation of stem cell therapy for neurological diseases. Transl Res 2010, 156:155-160.
35. Sergeant N., Delacourte A., Buée L. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 2005, 1739(2-3):179-197.
36. Uemura K., Kitagawa N., Kohno R., Kuzuya A., Kageyama T., Shibasaki H., Shimohama S. Presenilin 1 mediates retinoic acid-induced differentiation of SH-SY5Y cells through facilitation of Wnt signaling. J Neurosci Res 2003, 73:166-175.
37. Wischik C.M., Novak M., Edwards P.C., Klug A., Tichelaar W., Crowther R.A. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 1988, 85:4884-4888.
38. Wischik C.M., Novak M., Thøgersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 1988, 85:4506-4510.
39. Zilka N., Filipcik P., Koson P., Fialova L., Skrabana R., Zilkova M., Rolkova G., Kontsekova E., Novak M. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 2006, 580(15):3582-3588.
40. Zilka N., Kontsekova E., Novak M. Chaperone-like antibodies targeting misfolded tau protein: new vistas in the immunotherapy of neurodegenerative foldopathies. J Alzheimers Dis 2008, 15(2):169-179.
41. Zilkova M., Zilka N., Kovac A., Kovacech B., Skrabana R., Skrabanova M., Novak M. Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular model. J Alzheimers Dis 2011, 23(1):161-169.